Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Lantibio and TRB Chemedica sign agreement for Vismed

Jan. 17, 2006

Novagali completes phase II study of ophthalmic formulation of ciclosporin

Jan. 17, 2006

Vitragan MAA accepted for review

Jan. 13, 2006

PR Pharmaceuticals and OSI collaborate on sustained-release Macugen

Jan. 13, 2006

iDESTRIN relieves signs and symptoms of dry eye syndrome in postmenopausal women

Jan. 10, 2006

Phase II trial for NT-501 in dry AMD

Jan. 9, 2006

InSite Vision completes debt refinancing to support AzaSite development and filing

Jan. 4, 2006

Genentech submits BLA for Lucentis in wet AMD

Jan. 2, 2006

New beta-adrenoceptor antagonists for eye disorders reported by Othera

Dec. 29, 2005

Animal study begins for Acusolin for cataracts

Dec. 29, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...